Gemmer Asset Management LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gemmer Asset Management LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$4,000
-63.6%
95
-45.1%
0.00%
-100.0%
Q4 2021$11,000
+83.3%
173
+82.1%
0.00%0.0%
Q3 2021$6,000
-57.1%
95
-43.8%
0.00%
-50.0%
Q2 2021$14,000
+133.3%
169
+77.9%
0.00%
+100.0%
Q1 2021$6,000
-14.3%
950.0%0.00%0.0%
Q4 2020$7,000
+75.0%
950.0%0.00%0.0%
Q3 2020$4,000
-20.0%
95
-12.0%
0.00%0.0%
Q2 2020$5,000
+400.0%
108
+184.2%
0.00%
Q1 2020$1,000
-83.3%
38
-56.3%
0.00%
-100.0%
Q4 2019$6,000
+200.0%
870.0%0.00%
Q3 2019$2,0000.0%870.0%0.00%
-100.0%
Q2 2019$2,000870.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders